de-extinction

Dallas’ Colossal Foundation Joins IUCN in $4M ‘Race Against Time’ Effort to Prevent Extinction

by | Sep 17, 2026
The foundation and IUCN Species Survival Commission have launched a four-year partnership that will use Colossal Biosciences’ technology to improve tracking of endangered species, including overlooked fungi, plants, invertebrates, fishes and reptiles.
MORE
Colossal Tasmanian devil facial tumor.
Colossal Foundation Partners with the University of Tasmania to ‘Give Tasmanian Devils a Fighting Chance’
by | Jul 7, 2026
By using a vaccine and gene editing, the partners aim to fight a lethal cancer that has reduced the wild population of Tasmanian devils by 80% since the 1990s.
MORE
Dallas-Based Colossal and U.S. Fish and Wildlife Service Launch BioVault Initiative for Endangered Species
by | Jun 25, 2026
"By preserving the genetic blueprint of every endangered species in America, we're creating a living archive of Earth's biodiversity—a modern-day Noah's Ark built from DNA and a permanent genetic backup of our nation's most imperiled species," said Colossal Biosciences Co-Founder and CEO Ben Lamm.
MORE

Colossal Biosciences Names Australian De‑Extinction Scientist as Its Chief Biology Officer

by | Aug 20, 2025
Andrew Pask is known for his expertise in de-extinction science, developmental genetics, and conservation technologies. He leads the Thylacine Integrated Genomic Restoration Research Lab (TIGGR) at the University of Melbourne in Australia.
MORE
The South Island giant moa towered over New Zealand's forests for millions of years before becoming extinct within a century of Polynesian settlement around 1400 CE. Colossal Biosciences plans to resurrect the 500-pound birds using ancient DNA extracted from cave deposits and artificial egg technology. [Source image: Colossal Biosciences]
Colossal Biosciences Takes On De‑Extinction of New Zealand’s 12‑Foot Moa After Dire Wolf Milestone
by | Jul 9, 2025
The Dallas decacorn is scaling its de-extinction pipeline with indigenous leadership, a New Zealand subsidiary, and economic models for species preservation, including ecotourism opportunities. Filmmaker Sir Peter Jackson helped connect the collaborators, Colossal CEO Ben Lamm says.
MORE
Colossal Launches The Colossal Foundation with $50M for ‘BioVault’ Biobanking, Genetic Rescues, and More
by | Oct 1, 2024
The North Texas-based foundation aims to fight the "extinction crisis" with initiatives including Colossal Biovault—"the world's largest distributed biobanking initiative"—and an array of new efforts to both preserve and "de-extinct" wildlife.
MORE

Colossal Biosciences Adds Renowned Ancient DNA Expert as Chief Science Officer

by | Mar 19, 2024
Dallas-based Colossal said that in her new role, MacArthur Award winner Beth Shapiro will oversee continued expansion of the company's de-extinction and conservation science teams. The company previously announced plans to "de-extinct" the woolly mammoth, the Tasmanian tiger, and the dodo bird.
MORE
Director of Oscar-Winning ‘My Octopus Teacher’ To Make a Docuseries on Dallas-Based Colossal Biosciences
by | Feb 21, 2024
Colossal Biosciences and production partner Teton Ridge Entertainment have signed with James Reed, director of the Oscar-winning Netflix documentary "My Octopus Teacher," and his company Underdog Films, to produce the docuseries.
MORE
Hollywood Brand Veteran Takes CMO Helm at Colossal Biosciences to Bring De-Extinction to the Global Stage
by | Feb 2, 2024

Veteran marketing executive Emily Castel has joined Colossal Bioscience, the world’s first de-extinction company, as its first chief marketing officer, bringing her global entertainment and consumer brand experience to Colossal where she will lead global efforts to scale the company’s brand, experiences, consumer products, and emerging media properties....

MORE

Form Bio Spins Out of Colossal Bioscience to Offer Scientists the ‘Missing Piece’

by | Sep 27, 2022
Dallas-based Colossal Biosciences, the de-extinction company behind plans to bring back the woolly mammoth and thylacine, developed its own software solution "after reviewing everything available on the market." Now it's sharing the platform with the launch of Form Bio.

The spinout's technology tools can help drive the “entire molecular revolution” that is occurring in the life sciences and biotech space, in addition to bolstering the Lone Star state as a hub for the industry, says Chief Strategy Officer Claire Aldridge.
MORE